Chinanews Client Beijing, August 5 (Reporter Zhang Ni) A few days ago, the State Food and Drug Administration announced the "Annual Report on Drug Regulatory Statistics in 2019." Data shows that in 2019, regulatory agencies at all levels investigated and dealt with 77,000 drug cases, with a value of 1.99 billion yuan and fines of 390 million yuan.
Data map: counterfeit and inferior drugs photo by Zhong Xin
Data shows that as of the end of 2019, there were 4,529 raw material and preparation manufacturers nationwide. There are 544,000 companies holding the "Pharmaceutical Business License", including 14,000 wholesale companies; 6,701 retail chain companies, 29 million retail chain stores; and 234,000 retail pharmacies.
In addition, as of the end of 2019, there were 18,000 medical device manufacturers nationwide, including 8,232 companies that can produce Class I products, 10,033 companies that can produce Class II products, and 1977 companies that can produce Class III products. There are 5,060 cosmetics manufacturers.
In terms of registration and approval, in the new drug approval work in 2019, the National Bureau approved a total of 577 new drug clinical applications, 14 new drug certificates and approval document numbers for new drug production, and 35 approval document numbers; a total of 109 clinical applications were approved according to the new drug application procedures Approved to declare and produce 12 pieces according to the new drug application procedures.
The "Annual Report" also announced the investigation and handling of cases in 2019.
Data shows that in 2019, regulatory agencies at all levels investigated and dealt with 77,000 drug cases, with a value of 1.99 billion yuan, fines of 390 million yuan, confiscation of 110 million yuan of illegal income, banning 785 unlicensed businesses, and destroying counterfeit production and sales dens. 120, 1,394 households were ordered to suspend production and business, 127 licenses were revoked, and 1,258 were transferred to judicial organs.
In addition, in 2019, regulatory agencies at all levels investigated and dealt with 264 cases involving drug packaging materials with a value of 3.529 million yuan; 15,000 medical device cases with a value of 110 million yuan, a fine of 470 million yuan, and the confiscated amount of illegal income 2244.4 Ten thousand yuan, 133 unlicensed businesses were banned, 10 counterfeit production and sales dens were destroyed, 120 businesses were ordered to suspend production and business, 17 licenses were revoked, and 25 were transferred to judicial authorities.
In the cosmetics field, in 2019, regulatory agencies at all levels investigated and dealt with 8703 cosmetics cases with a value of 180 million yuan, fines 59.82 million yuan, confiscated 33.871 million yuan of illegal income, ordered suspend production and business 254, and transferred 36 cases to judicial authorities. (Finish)